News & Resources
Recent Posts
BD and Decode Health: Innovating to bring molecular tests to patients’ homes
We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.
As Seen In
Podcasts
Publications
News
Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development
Decode Health, a healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, today announced a new phase of its collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to empower drug and diagnostics research and development in the growing fields of metabolic disease and autoimmune neurology.
Decode Health Adds Board Chairman and Chief Medical Officer
Decode Health, a rapidly growing healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, announced today that two healthcare industry veterans will expand their current advisory roles within the company.
Decode Health Earns DataRobot’s AI Innovator Award
Decode Health was recently recognized with an AI Innovator Award at the DataRobot AIX 22 global virtual conference. DataRobot is a Boston-based AI cloud platform company that works with customers worldwide across industries and verticals, including almost 40% of Fortune 50 companies.
Blog
Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics
According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.
Using Predictive Community Insights to Slow COVID-19 Hospitalizations
Just as national health officials warned ahead of the holiday season, the winter months of 2020-21 have proven to be the most challenging period of the COVID-19 pandemic so far. In Tennessee alone, there have been more than 10,000 deaths and nearly 18,000 hospitalizations resulting from SARS-CoV-2 infection. At distinct [read more...]
Addressing the Emergent Issue of Long COVID
Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. Commonly referred to as long COVID, scientists are just beginning to understand the long-term effects [read more...]
